Filing Details

Accession Number:
0001214659-25-010933
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-07-25 20:00:10
Reporting Period:
2025-07-23
Filing Date:
2025-07-25
Accepted Time:
2025-07-25 20:00:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1677077 Alzamend Neuro Inc. ALZN () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1212502 Iii C Milton Ault 11411 Southern Highlands Parkway
Suite 240
Las Vegas NV 89141
No No No No
Transaction Summary
Sold: 69,137 shares Avg. Price: $2.95 Total Value: $203,820.78
Number of Shares After Transactions: 82,552 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-07-23 143,429 $2.32 151,689 No 4 C Indirect By Ault Lending, LLC
Common Stock Disposition 2025-07-23 59,516 $2.95 92,173 No 4 S Indirect By Ault Lending, LLC
Common Stock Disposition 2025-07-24 9,621 $2.93 82,552 No 4 S Indirect By Ault Lending, LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect By Ault Lending, LLC
No 4 S Indirect By Ault Lending, LLC
No 4 S Indirect By Ault Lending, LLC
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series B Convertible Preferred Stock Disposition 2025-07-23 333 $1,000.00 143,429 $2.32
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,767 2024-01-31 No 4 C Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,843 Direct
Common Stock 11,068 Indirect By Ault Life Sciences, Inc.
Common Stock 61 Indirect By Ault Life Sciences Fund, LLC
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Common Stock Purchase Warrants $108.00 2024-08-01 2029-08-01 13,556 13,556 Indirect
Common Stock Common Stock Purchase Warrants $108.00 2024-09-27 2029-09-27 8,667 8,667 Indirect
Common Stock Common Stock Purchase Warrants $108.00 2024-10-30 2029-10-30 23,334 23,334 Indirect
Common Stock Common Stock Purchase Warrants $4,050.00 2020-08-31 2025-08-31 12 12 Indirect
Expiration Date Amount Remaning Holdings Nature of Ownership
2029-08-01 13,556 13,556 Indirect
2029-09-27 8,667 8,667 Indirect
2029-10-30 23,334 23,334 Indirect
2025-08-31 12 12 Indirect
Footnotes
  1. Represents shares of common stock received upon conversion of Series B convertible preferred stock ("Series B Preferred").
  2. Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Hyperscale Data, Inc. ("HSD"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.
  3. Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
  4. Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.
  5. The Conversion Price of the Series B Preferred is subject to adjustment as set forth in that certain of Designation of Preferences, Rights and Limitations of the Series B Convertible Voting Preferred Stock.
  6. The shares of Series B Preferred have no expiration date.
  7. Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by HSD.